BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8738849)

  • 1. The penetration of novel intravenous cephalosporins into the lung.
    Baldwin DR
    J Chemother; 1996 Feb; 8 Suppl 2():71-82. PubMed ID: 8738849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory tract penetration of quinolone antimicrobials: a case in study.
    Ritrovato CA; Deeter RG
    Pharmacotherapy; 1991; 11(1):38-49. PubMed ID: 2020610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of tissue penetration of antibiotics in the respiratory tract.
    Lambert HP
    Scand J Infect Dis Suppl; 1978; (14):262-6. PubMed ID: 279980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of intravenous antibiotics from the lung into the pleural space after pulmonary resection.
    Sakuma T; Kubo H; Tanita T; Koike K; Fujimura S
    J Thorac Cardiovasc Surg; 1994 Mar; 107(3):955-7. PubMed ID: 8127134
    [No Abstract]   [Full Text] [Related]  

  • 5. Cefepime concentrations in bronchial mucosa and serum following a single 2 gram intravenous dose.
    Chadha D; Wise R; Baldwin DR; Andrews JM; Ashby JP; Honeybourne D
    J Antimicrob Chemother; 1990 Jun; 25(6):959-63. PubMed ID: 2196260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The penetration of cefpirome into the potential sites of pulmonary infection.
    Baldwin DR; Maxwell SR; Honeybourne D; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1991 Jul; 28(1):79-86. PubMed ID: 1769946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Permeability of the air-blood barrier to macromolecules].
    Bernaudin JF; Bignon J
    Ann Anesthesiol Fr; 1980; 21(6):629-33. PubMed ID: 6111270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments.
    Cook PJ; Andrews JM; Wise R; Honeybourne D
    J Antimicrob Chemother; 1996 Feb; 37(2):331-9. PubMed ID: 8707743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of right hemithoracic irradiation on ceftazidime penetration into the alveolar space in rats.
    Murata T; Imamura M; Akagi K; Nasu R; Akai M; Uda M
    Radiat Med; 1998; 16(6):457-60. PubMed ID: 9929146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study on pulmonary tissue uptake of flomoxef].
    Imaizumi M; Watanabe H; Ojika T; Fujita K; Sakakibara M; Kondo D; Nishimura M; Abe T
    Jpn J Antibiot; 1991 Jan; 44(1):22-34. PubMed ID: 2041145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivering antibacterials to the lungs: considerations for optimizing outcomes.
    Cazzola M; Blasi F; Terzano C; Matera MG; Marsico SA
    Am J Respir Med; 2002; 1(4):261-72. PubMed ID: 14720046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors influencing the penetration of antibiotics at the level of the pulmonary parenchyma and bronchial secretion].
    Koda YK; Menezes JJ; Rozov T
    Rev Paul Med; 1981; 97(4-6):68-74. PubMed ID: 7336059
    [No Abstract]   [Full Text] [Related]  

  • 14. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
    Conte JE; Golden JA; Kelley MG; Zurlinden E
    Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state plasma and bronchopulmonary characteristics of clarithromycin extended-release tablets in normal healthy adult subjects.
    Gotfried MH; Danziger LH; Rodvold KA
    J Antimicrob Chemother; 2003 Sep; 52(3):450-6. PubMed ID: 12888589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchopulmonary penetration of ciprofloxacin.
    Loos U; Marklein G; Scholl H
    J Chemother; 1989 Jul; 1(4 Suppl):560-1. PubMed ID: 16312532
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of cefotaxime serum and lung concentrations in 6 patients with thoracotomy (author's transl)].
    Pous J; Peltier M; Berthoumieu C; Monnier J
    Nouv Presse Med; 1981 Feb; 10(8):585-6. PubMed ID: 6259597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
    Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
    Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 453():1-365. PubMed ID: 12594522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Penetration and persistence of rifampicin at the tissue and lesion level].
    Blasi A; Ninni A; Olivieri D
    Arch Monaldi; 1971; 26(5):407-21. PubMed ID: 5173324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.